Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: what do we tell patients?
作者信息
Lee Minna K, Robson Mark E
机构信息
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Breast Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
出版信息
J Natl Cancer Inst. 2023 Nov 8;115(11):1243-1245. doi: 10.1093/jnci/djad129.
Abstract
摘要
相似文献
1
Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: what do we tell patients?
J Natl Cancer Inst. 2023 Nov 8;115(11):1243-1245. doi: 10.1093/jnci/djad129.
2
Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer.
Ann Oncol. 2019 Mar 1;30(3):412-417. doi: 10.1093/annonc/mdy515.
3
Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.
Eur J Cancer. 2013 Sep;49(14):2979-85. doi: 10.1016/j.ejca.2013.04.028. Epub 2013 May 21.
4
Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.
Cancer. 2020 Jan 15;126(2):271-280. doi: 10.1002/cncr.32540. Epub 2019 Oct 3.
5
Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
Genes Chromosomes Cancer. 2004 Mar;39(3):236-48. doi: 10.1002/gcc.10321.
6
The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first-degree relative with breast cancer.
Clin Genet. 2018 May;93(5):1063-1068. doi: 10.1111/cge.13191. Epub 2018 Mar 25.
7
BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Mol Genet Genomic Med. 2019 Mar;7(3):e493. doi: 10.1002/mgg3.493. Epub 2019 Jan 16.
8
CCND1 and ZNF217 gene amplification is equally frequent in BRCA1 and BRCA2 associated and non-BRCA breast cancer.
Neoplasma. 2010;57(4):325-32. doi: 10.4149/neo_2010_04_325.
9
HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.
PLoS One. 2013;8(2):e56055. doi: 10.1371/journal.pone.0056055. Epub 2013 Feb 8.
10
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
J Clin Oncol. 2009 Dec 10;27(35):5887-92. doi: 10.1200/JCO.2008.19.9430. Epub 2009 Oct 26.
本文引用的文献
1
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.
J Natl Cancer Inst. 2023 Nov 8;115(11):1318-1328. doi: 10.1093/jnci/djad116.
2
Cancer Effects of Low to Moderate Doses of Ionizing Radiation in Young People with Cancer-Predisposing Conditions: A Systematic Review.
Cancer Epidemiol Biomarkers Prev. 2022 Oct 4;31(10):1871-1889. doi: 10.1158/1055-9965.EPI-22-0393.
3
Comparison of Outcomes Between BRCA Pathogenic Variant Carriers Undergoing Breast-Conserving Surgery Versus Mastectomy.
Ann Surg Oncol. 2022 Aug;29(8):4706-4713. doi: 10.1245/s10434-022-11756-1. Epub 2022 May 18.
4
Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis.
Breast Cancer. 2022 Mar;29(2):314-323. doi: 10.1007/s12282-021-01312-2. Epub 2021 Nov 11.
5
Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.
J Clin Oncol. 2020 Jun 20;38(18):2080-2106. doi: 10.1200/JCO.20.00299. Epub 2020 Apr 3.
6
Aneuploidy and a deregulated DNA damage response suggest haploinsufficiency in breast tissues of mutation carriers.
Sci Adv. 2020 Jan 29;6(5):eaay2611. doi: 10.1126/sciadv.aay2611. eCollection 2020 Jan.
7
The BRCA Tumor Suppressor Network in Chromosome Damage Repair by Homologous Recombination.
Annu Rev Biochem. 2019 Jun 20;88:221-245. doi: 10.1146/annurev-biochem-013118-111058. Epub 2019 Mar 27.
8
Preoperative genetic testing impacts surgical decision making in BRCA mutation carriers with breast cancer: a retrospective cohort analysis.
Hered Cancer Clin Pract. 2017 Jul 26;15:11. doi: 10.1186/s13053-017-0071-z. eCollection 2017.
9
Comparing oncoplastic breast conserving surgery with mastectomy and immediate breast reconstruction: Case-matched patient reported outcomes.
J Plast Reconstr Aesthet Surg. 2017 Oct;70(10):1377-1385. doi: 10.1016/j.bjps.2017.05.009. Epub 2017 May 18.
10
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
JAMA. 2017 Jun 20;317(23):2402-2416. doi: 10.1001/jama.2017.7112.
Zotero 插件